Evofem rises after Supreme Court overturns Roe V Wade

Evofem Biosciences

27/06/2022 12:34

** Shares of women's contraception maker Evofem Biosciences
 EVFM.O  soar 89% at $0.33 premarket
    ** Shares rise after U.S. Supreme Court on Fri overturned
1973 Roe v. Wade abortion landmark ruling  urn:newsml:reuters.com:*:nL1N2YB15Z
    ** Brokerage Laidlaw & Co reiterates "buy" rating; says
rising concern of abortion access could bode well for sales of
co's flagship contraceptive vaginal gel, Phexxi
    ** Last month, co reported that its Q1 Phexxi sales had
risen 19% compared to Q4  urn:newsml:reuters.com:*:nPnbBvPDna
    ** Up to last close, EVFM fell 93.4% this year

 (Reporting by Nandhini Srinivasan)
 ((Nandhini.Srinivasan@thomsonreuters.com;))